Biofrontera AG (XTER:B8FK) Marketable Securities : €1.56 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Biofrontera AG's Marketable Securities for the quarter that ended in Dec. 2023 was €1.56 Mil.

Biofrontera AG's annual Marketable Securities increased from Dec. 2021 (€0.06 Mil) to Dec. 2022 (€0.88 Mil) and increased from Dec. 2022 (€0.88 Mil) to Dec. 2023 (€1.56 Mil).

Biofrontera AG Marketable Securities Historical Data

The historical data trend for Biofrontera AG's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG Marketable Securities Chart

Biofrontera AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

1.08

0.01

0.06

0.88

1.56

Biofrontera AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															0.88	1.32	1.35	1.34	1.56

Biofrontera AG Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Biofrontera AG (XTER:B8FK) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Biofrontera AG Marketable Securities Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofrontera AG (XTER:B8FK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8FK) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

B8F:Germany B8F:Germany B8F:Germany

Address

Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377

Website

https://www.biofrontera.com

Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8FK) Headlines

No Headlines